# OnCo record paper-checkmate-227-int-j-clin-oncol-2023-update (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-checkmate-227-int-j-clin-oncol-2023-update/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-checkmate-227-int-j-clin-oncol-2023-update" ;
  schema:name "First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1"@en ;
  schema:description "Later report from the CheckMate 227 trial registered as NCT02477826, in International journal of clinical oncology (2023); its title describes an updated or longer-term analysis."@en ;
  schema:url <https://onco.cc/key-papers/paper-checkmate-227-int-j-clin-oncol-2023-update/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1007/s10147-023-02390-2>, <https://pubmed.ncbi.nlm.nih.gov/37548831/>, <https://europepmc.org/article/MED/37548831>, <https://clinicaltrials.gov/study/NCT02477826> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1007/s10147-023-02390-2> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Nishio M, Ohe Y, Ikeda S, et al." ;
  onco:trials <https://onco.cc/trials/checkmate-227/> ;
  onco:journals <https://onco.cc/journals/international-journal-of-clinical-oncology/> .